top of page

NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML

Product details

Registration number: SIN16058P

Classification: Prescription Only

Active ingredients: Dinalbuphine sebacate

Strength: 75mg/ ml

Dosage form: INJECTION, SOLUTION

Route: INTRAMUSCULAR

Registrant: TAEVAS LIFE SCIENCES PTE LTD

ATC code: Pending

HSA approval date: 15 December 2020

Manufacturer(s): Hsinchu Plant of UBI Pharma Inc.

Manufacturing country/countries: TAIWAN

What are the HSA registration number and classification for NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16058P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Dinalbuphine sebacate

Strength: 75mg/ ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML?

According to the HSA dataset updated 7 August 2026:

Registrant: TAEVAS LIFE SCIENCES PTE LTD

Source for this answer

Which manufacturers and countries are listed for NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Hsinchu Plant of UBI Pharma Inc.

Manufacturing country/countries: TAIWAN

Source for this answer

Where can I look up NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16058P or the exact product name NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this NALDEBAIN® EXTENDED RELEASE INJECTION 75MG/ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16058P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page